Pfaller, M. A.

Wild-type MIC distributions and epidemiological cutoff values for amphotericin B, flucytosine, and itraconazole and Candida spp. as determined by CLSI broth microdilution.

Pfaller, M. A., Espinel-Ingroff, A., Canton, E., Castanheira, M., Cuenca-Estrella, M., Diekema, D. J., Fothergill, A., Fuller, J., Ghannoum, M., Jones, R. N., et al. (2012) · Journal of Clinical Microbiology

Antifungal resistance and susceptibilityYeasts and Rust Fungi Studies

Cited by 174

In Vitro Activities of Anidulafungin against More than 2,500 Clinical Isolates of Candida spp., Including 315 Isolates Resistant to Fluconazole

Pfaller, M. A., Boyken, L., Hollis, R. J., Messer, S. A., Tendolkar, S., & Diekema, D. J. (2005) · Journal of Clinical Microbiology

Antifungal resistance and susceptibilityFungal Plant Pathogen Control

Cited by 161

Antifungal susceptibility patterns of a global collection of fungal isolates: results of the SENTRY Antifungal Surveillance Program (2013)

Castanheira, M., Messer, S. A., Rhomberg, P. R., & Pfaller, M. A. (2016) · Diagnostic Microbiology and Infectious Disease

Antifungal resistance and susceptibilityFungal Plant Pathogen Control

Cited by 159

Contemporary tools for the diagnosis and management of invasive mycoses

Alexander, B. D., & Pfaller, M. A. (2006) · Clinical Infectious Diseases

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 147

Activity of MGCD290, a Hos2 Histone Deacetylase Inhibitor, in Combination with Azole Antifungals against Opportunistic Fungal Pathogens

Pfaller, M. A., Messer, S. A., Georgopapadakou, N., Martell, L. A., Besterman, J. M., & Diekema, D. J. (2009) · Journal of Clinical Microbiology

Antifungal resistance and susceptibilityHistone Deacetylase Inhibitors Research

Cited by 143

National Epidemiology of Mycoses Survey: A Multicenter Study of Strain Variation and Antifungal Susceptibility Among Isolates of Candida Species

Pfaller, M. A., Messer, S. A., Houston, A., Rangel-Frausto, M. S., Wiblin, T., Blumberg, H. M., Edwards, J. E., Jarvis, W., Martin, M. A., Neu, H. C., et al. (1998) · Diagnostic Microbiology and Infectious Disease

Antifungal resistance and susceptibilityYeasts and Rust Fungi Studies

Cited by 141

In vivo pharmacodynamic characterization of anidulafungin in a neutropenic murine candidiasis model

Andes, D., Diekema, D. J., Pfaller, M. A., Prince, R. A., Marchillo, K., Ashbeck, J., & Hou, J. (2008) · Antimicrobial Agents and Chemotherapy

Antifungal resistance and susceptibilityAntibiotics Pharmacokinetics and Efficacy

Cited by 140

Trends in Antifungal Use and Epidemiology of Nosocomial Yeast Infections in a University Hospital

Berrouane, Y. F., Herwaldt, L. A., & Pfaller, M. A. (1999) · Journal of Clinical Microbiology

Antifungal resistance and susceptibilityInfection Control in Healthcare

Cited by 136

In Vivo Pharmacodynamic Target Investigation for Micafungin against Candida albicans and C. glabrata in a Neutropenic Murine Candidiasis Model

Andes, D. R., Diekema, D. J., Pfaller, M. A., Marchillo, K., & Bohrmueller, J. (2008) · Antimicrobial Agents and Chemotherapy

Antifungal resistance and susceptibilityAntibiotics Pharmacokinetics and Efficacy

Cited by 134

In Vitro Activities of 5-Fluorocytosine against 8,803 Clinical Isolates of Candida spp.: Global Assessment of Primary Resistance Using National Committee for Clinical Laboratory Standards Susceptibility Testing Methods

Pfaller, M. A., Messer, S. A., Boyken, L., Huynh, H., Hollis, R. J., & Diekema, D. J. (2002) · Antimicrobial Agents and Chemotherapy

Antifungal resistance and susceptibilityFungal Plant Pathogen Control

Cited by 132

Clinical breakpoints for voriconazole and Candida spp. revisited: review of microbiologic, molecular, pharmacodynamic, and clinical data as they pertain to the development of species-specific interpretive criteria

Pfaller, M. A., Andes, D., Arendrup, M. C., Diekema, D. J., Espinel-Ingroff, A., Alexander, B. D., Brown, S. D., Chaturvedi, V., Fowler, C. L., Ghannoum, M. A., et al. (2011) · Diagnostic Microbiology and Infectious Disease

Antifungal resistance and susceptibilityBacterial Identification and Susceptibility Testing

Cited by 130

Isavuconazole, micafungin, and 8 comparator antifungal agents' susceptibility profiles for common and uncommon opportunistic fungi collected in 2013: temporal analysis of antifungal drug resistance using CLSI species-specific clinical breakpoints and proposed epidemiological cutoff values

Pfaller, M. A., Rhomberg, P. R., Messer, S. A., Jones, R. N., & Castanheira, M. (2015) · Diagnostic Microbiology and Infectious Disease

Antifungal resistance and susceptibilityFungal Plant Pathogen Control

Cited by 127

Low Prevalence of fks1 Hot Spot 1 Mutations in a Worldwide Collection of Candida Strains

Castanheira, M., Woosley, L. N., Diekema, D. J., Messer, S. A., Jones, R. N., & Pfaller, M. A. (2010) · Antimicrobial Agents and Chemotherapy

Antifungal resistance and susceptibilityFungal Plant Pathogen Control

Cited by 125

Multilaboratory study of epidemiological cutoff values for detection of resistance in eight Candida species to fluconazole, posaconazole, and voriconazole

Espinel-Ingroff, A., Pfaller, M. A., Bustamante, B., Canton, E., Fothergill, A., Fuller, J., Gonzalez, G. M., Lass-Flörl, C., Lockhart, S. R., Martin-Mazuelos, E., et al. (2014) · Antimicrobial Agents and Chemotherapy

Antifungal resistance and susceptibilityYeasts and Rust Fungi Studies

Cited by 105

Activities of E1210 and Comparator Agents Tested by CLSI and EUCAST Broth Microdilution Methods against Fusarium and Scedosporium Species Identified Using Molecular Methods

Castanheira, M., Duncanson, F. P., Diekema, D. J., Guarro, J., Jones, R. N., & Pfaller, M. A. (2012) · Antimicrobial Agents and Chemotherapy

Antifungal resistance and susceptibilityFungal Plant Pathogen Control

Cited by 98

In Vitro Activity of a New Oral Glucan Synthase Inhibitor (MK-3118) Tested against Aspergillus spp. by CLSI and EUCAST Broth Microdilution Methods

Pfaller, M. A., Messer, S. A., Motyl, M. R., Jones, R. N., & Castanheira, M. (2013) · Antimicrobial Agents and Chemotherapy

Antifungal resistance and susceptibilityFungal and yeast genetics research

Cited by 98

Activities of Micafungin against 315 Invasive Clinical Isolates of Fluconazole-Resistant Candida spp

Messer, S. A., Diekema, D. J., Boyken, L., Tendolkar, S., Hollis, R. J., & Pfaller, M. A. (2006) · Journal of Clinical Microbiology

Antifungal resistance and susceptibilityFungal Plant Pathogen Control

Cited by 97

Hospital Specificity, Region Specificity, and Fluconazole Resistance of Candida albicans Bloodstream Isolates

Pfaller, M. A., Lockhart, S. R., Pujol, C., Swails-Wenger, J. A., Messer, S. A., Edmond, M. B., Jones, R. N., Wenzel, R. P., & Soll, D. R. (1998) · Journal of Clinical Microbiology

Antifungal resistance and susceptibilityYeasts and Rust Fungi Studies

Cited by 91

Use of Epidemiological Cutoff Values To Examine 9-Year Trends in Susceptibility of Aspergillus Species to the Triazoles

Pfaller, M., Boyken, L., Hollis, R., Kroeger, J., Messer, S., Tendolkar, S., & Diekema, D. (2011) · Journal of Clinical Microbiology

Antifungal resistance and susceptibilityAntibiotic Resistance in Bacteria

Cited by 91

Strain delineation and antifungal susceptibilities of epidemiologically related and unrelated isolates of Candida lusitaniae

Pfaller, M. A., Messer, S. A., & Hollis, R. J. (1994) · Diagnostic Microbiology and Infectious Disease

Antifungal resistance and susceptibilityYeasts and Rust Fungi Studies

Cited by 86

Differential activity of the oral glucan synthase inhibitor SCY-078 against wild-type and echinocandin-resistant strains of Candida species

Pfaller, M. A., Messer, S. A., Rhomberg, P. R., Borroto-Esoda, K., & Castanheira, M. (2017) · Antimicrobial Agents and Chemotherapy

Antifungal resistance and susceptibilityFungal Plant Pathogen Control

Cited by 84

Optimal Susceptibility Testing Conditions for Detection of Azole Resistance in Aspergillus spp.: NCCLS Collaborative Evaluation

Espinel-Ingroff, A., Bartlett, M., Chaturvedi, V., Ghannoum, M., Hazen, K. C., Pfaller, M. A., Rinaldi, M., & Walsh, T. J. (2001) · Antimicrobial Agents and Chemotherapy

Antifungal resistance and susceptibilityBacterial Identification and Susceptibility Testing

Cited by 83

Frequency of fks Mutations among Candida glabrata Isolates from a 10-Year Global Collection of Bloodstream Infection Isolates

Castanheira, M., Woosley, L. N., Messer, S. A., Diekema, D. J., Jones, R. N., & Pfaller, M. A. (2014) · Antimicrobial Agents and Chemotherapy

Antifungal resistance and susceptibilityFungal Plant Pathogen Control

Cited by 82

Geographic variation in the frequency of isolation and fluconazole and voriconazole susceptibilities of Candida glabrata: an assessment from the ARTEMIS DISK Global Antifungal Surveillance Program

Pfaller, M. A., Diekema, D. J., Gibbs, D. L., Newell, V. A., Barton, R., Bijie, H., Bille, J., Chang, S.-C., da Luz Martins, M., Duse, A., et al. (2010) · Diagnostic Microbiology and Infectious Disease

Antifungal resistance and susceptibilityFungal Plant Pathogen Control

Cited by 80